Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Why minorities need more representation in breast cancer research

Ananth Ravi, PhD
Conditions
April 3, 2024
Share
Tweet
Share

I’ve always been interested in democratizing health care and have tried to incorporate this in my image-guided therapeutics research.

As a health care CEO, I’ve been afforded the opportunity to broaden my research scope and examine a personal area of interest: disparities in health care and how we can address these through innovation and scientific inquiry.

Racial disparities in health care outcomes are a pervasive issue, and breast cancer is not immune to this problem. Women of color are more inclined to be diagnosed with later-stage cancer and are, therefore, more likely to face a worse prognosis and lower survival rates than Caucasian women.

Significant factors contributing to the divide in outcomes include tumor biology in combination with quality of care. But much remains to be understood.

Physicians and researchers aim to understand disparities through scientific inquiry. One avenue is clinical trials, which are crucial in developing advances in breast cancer treatments and therapeutics.

Race and income play a complex factor in clinical trial participation. Visible minorities comprise a significant proportion of the U.S. population, nearly 44 percent. However, they only represent less than 10 to 15 percent of the participants in breast cancer clinical trials.

Without minority representation in clinical trials, the success of screening strategies may be incorrect because all aspects of the population are not targeted. Diversity amongst clinical trial participants is crucial to help ensure generalizability of the results.

The results of a study by researchers from Duke University and the University of Illinois may provide possible answers to the lack of diversity in trials. The researchers attempted to determine how breast surgical oncology patients’ participation in clinical trials changed over a 12-year period and what characteristics are associated with participation.

The trial demonstrated that targeted programs have the capacity to reverse the impacts of social disparities in clinical trial participation. This review showed that towards the end of the 12-year period, enrollment of lower-income Black, Asian/Pacific Islanders, and Hispanics had surpassed their higher-income counterparts. They noted gaps that still need to be addressed:

  • Recruitment strategies targeting Black patients will need to address barriers, such as a lack of trust in the medical community in general.
  • The representation of Hispanic Americans remains low despite them being the largest growing demographic in the U.S. This was ascribed to several factors, including failure to provide translated educational material and exclusions related to insurance status.

In order to increase minority representation in clinical trials, socioeconomic disparities must be further examined. In comparison to our understanding of breast cancer biology, our understanding of the determinants of inequality is still nascent.

A concerted large-scale effort is required to truly understand the intricacies of this leading health care issue.

Ananth Ravi is a health care executive.

Prev

Mental health support for teens [PODCAST]

April 2, 2024 Kevin 0
…
Next

10 harsh truths doctors must understand to avoid burnout

April 3, 2024 Kevin 0
…

ADVERTISEMENT

Tagged as: Oncology/Hematology

Post navigation

< Previous Post
Mental health support for teens [PODCAST]
Next Post >
10 harsh truths doctors must understand to avoid burnout

ADVERTISEMENT

Related Posts

  • Why new cancer treatments cannot save us

    Yongjia Wang
  • Pandemic aftermath: Navigating a new normal in health, education, and social dynamics

    Susan Levenstein, MD
  • “System-ness”: the key to successful health care transformation

    Robert Pearl, MD
  • Timely treatment decisions: the promise of surrogate markers

    Layla Parast, PhD
  • Cancer of the future: diagnosis, treatment, and impact on the health care system and patients

    Eugene Chan, MD
  • Questions about pharma pricing and marketing

    Martha Rosenberg

More in Conditions

  • How veteran health care is being transformed by tech and teamwork

    Deborah Lafer Scher
  • What Elon Musk and Diddy reveal about the price of power

    Osmund Agbo, MD
  • Understanding depression beyond biology: the power of therapy and meaning

    Maire Daugharty, MD
  • Why medicine must stop worshipping burnout and start valuing humanity

    Sarah White, APRN
  • Why perinatal mental health is the top cause of maternal death in the U.S.

    Sheila Noon
  • A world without vaccines: What history teaches us about public health

    Drew Remignanti, MD, MPH
  • Most Popular

  • Past Week

    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • How New Mexico became a malpractice lawsuit hotspot

      Patrick Hudson, MD | Physician
    • Why doctors are reclaiming control from burnout culture

      Maureen Gibbons, MD | Physician
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy
    • How veteran health care is being transformed by tech and teamwork

      Deborah Lafer Scher | Conditions
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • Why flashy AI tools won’t fix health care without real infrastructure

      David Carmouche, MD | Tech
  • Recent Posts

    • How veteran health care is being transformed by tech and teamwork

      Deborah Lafer Scher | Conditions
    • Why judgment is hurting doctors—and how mindfulness can heal

      Jessie Mahoney, MD | Physician
    • Why medical schools must ditch lectures and embrace active learning

      Arlen Meyers, MD, MBA | Education
    • Why helping people means more than getting an MD

      Vaishali Jha | Education
    • How digital tools are reshaping the doctor-patient relationship

      Vineet Vishwanath | Tech
    • Why evidence-based management may be an effective strategy for stronger health care leadership and equity

      Olumuyiwa Bamgbade, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • How New Mexico became a malpractice lawsuit hotspot

      Patrick Hudson, MD | Physician
    • Why doctors are reclaiming control from burnout culture

      Maureen Gibbons, MD | Physician
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy
    • How veteran health care is being transformed by tech and teamwork

      Deborah Lafer Scher | Conditions
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • Why flashy AI tools won’t fix health care without real infrastructure

      David Carmouche, MD | Tech
  • Recent Posts

    • How veteran health care is being transformed by tech and teamwork

      Deborah Lafer Scher | Conditions
    • Why judgment is hurting doctors—and how mindfulness can heal

      Jessie Mahoney, MD | Physician
    • Why medical schools must ditch lectures and embrace active learning

      Arlen Meyers, MD, MBA | Education
    • Why helping people means more than getting an MD

      Vaishali Jha | Education
    • How digital tools are reshaping the doctor-patient relationship

      Vineet Vishwanath | Tech
    • Why evidence-based management may be an effective strategy for stronger health care leadership and equity

      Olumuyiwa Bamgbade, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Why minorities need more representation in breast cancer research
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...